In IBD, bacterial metabolites such as acetate, butyrate, and propionate drive the expression of MMP-1, MMP-2, MMP-3, and MMP-9, contributing to tissue damage and barrier dysfunction. Here, MMP9 is linked to inflammatory bowel disease.